Skip to content
  • Investor Relationship
  • .
  • Investor Relationship
  • .
  • Home
  • Product Center
    • Machine perfusion LifePort/KPS-1
    • Organ preservation solution SPS-1
    • TDM(CsA、FK、MPA、RAPA)
    • Immunosuppressants FK
    • Post transplant dynamic monitoring
    • HLA Typing
    • Antibody test DSA、 C1q、 PRA
    • Service & Support
  • R&D and Production Center
  • New Transplant Platform
  • Talent Center
    • Social Recruitment
    • Campus Recruitment
  • Chinese
Menu
  • Home
  • Product Center
    • Machine perfusion LifePort/KPS-1
    • Organ preservation solution SPS-1
    • TDM(CsA、FK、MPA、RAPA)
    • Immunosuppressants FK
    • Post transplant dynamic monitoring
    • HLA Typing
    • Antibody test DSA、 C1q、 PRA
    • Service & Support
  • R&D and Production Center
  • New Transplant Platform
  • Talent Center
    • Social Recruitment
    • Campus Recruitment
  • Chinese
  • Home
  • Product Center
    • Machine perfusion LifePort/KPS-1
    • Organ preservation solution SPS-1
    • TDM(CsA、FK、MPA、RAPA)
    • Immunosuppressants FK
    • Post transplant dynamic monitoring
    • HLA Typing
    • Antibody test DSA、 C1q、 PRA
    • Service & Support
  • R&D and Production Center
  • New Transplant Platform
  • Talent Center
    • Social Recruitment
    • Campus Recruitment
  • Investor Relationship
  • .
  • CONTACT US
  • Chinese
Menu
  • Home
  • Product Center
    • Machine perfusion LifePort/KPS-1
    • Organ preservation solution SPS-1
    • TDM(CsA、FK、MPA、RAPA)
    • Immunosuppressants FK
    • Post transplant dynamic monitoring
    • HLA Typing
    • Antibody test DSA、 C1q、 PRA
    • Service & Support
  • R&D and Production Center
  • New Transplant Platform
  • Talent Center
    • Social Recruitment
    • Campus Recruitment
  • Investor Relationship
  • .
  • CONTACT US
  • Chinese
CONTACT US

Category: Uncategorized

Starlight Starlight | OPO High-End Innovation Forum Phase II Online Seminar: Cutting-edge Information Sharing on Mechanical Perfusion

点击蓝字关注我们 前言 近日,由上海健耕医药和IShareForLife智享学术社区举办的“星辰OPO高端创新 […]

GcfDNA bridges DSA shortcomings with joint application of early warning AMR

点击蓝字关注我们 本世纪初以来,在肾移植领域抗体介导排斥反应 (antibody‑mediated rejec […]

The 2nd GcfDNA Expert Advisor Workshop was successfully held: Monitoring Kidney Injury, Early Warning ABMR

点击蓝字关注我们 前言 2022年9月29日,由健耕医药举办的“第二届GcfDNA专家顾问研讨会”如期在线上成 […]

Comparative pharmacokinetics of different formulations of tacrolimus in stable renal transplant recipients

点击蓝字关注我们 他克莫司是大多数肾移植受者免疫抑制药物治疗的一个组成部分,超过90%的肾移植受者接受含他克莫 […]

Starlight Starlight|OPO High-end Innovation Forum Phase II-Mechanical Perfusion (Online)

点击蓝字关注我们 众所周知器官移植作为治疗各种终末期器官功能衰竭的重要手段,已经成功挽救了数以百万计患者的生命 […]

ddPCR - Advantages of GcfDNA in dynamic monitoring after transplantation

点击蓝字关注我们 器官排斥反应是器官移植领域的主要问题,移植后监测可以避免移植物过早失功。供体来源游离 DNA […]

New Seedling Public Welfare | "Relay for Life" Charity Relief Action - Wuhan and Jingzhou Tour

点击蓝字关注我们   我国每年有1500名青少年、少年儿童接受器官移植手术重获新生。但完成手术只是成长的第一步 […]

New Life | Application for 2022 New Life Scholarship is now open!

点击蓝字关注我们 新苗助学公益项目是由中国器官移植发展基金会发起,新耕植协办的生命接力公益救助行动品牌行动中针 […]

The important value of GcfDNA dynamic monitoring after renal transplantation

前言 随着肾移植取得巨大进展,肾移植术后并发症、免疫抑制药物调整等均会影响移植物的功能与存活,移植物术后的动态 […]

Uptake patterns of peak tacrolimus pentamidine and associated pharmacogenomic variation in renal transplant recipients

他克莫司是实体器官移植中最常用的免疫抑制药物。他克莫司的治疗窗口窄,患者间生物利用度变异性高。剂量不足增加排斥 […]

Mechanical perfusion improves myocardial metabolism and function and reduces the risk of death

点击蓝字关注我们 前言 最近Nature子刊发表的文章表明心脏细胞通过细胞内离子水平的变化来调节昼夜节律,当心 […]

World's First Successful Porcine Kidney Allograft | Barriers to Allogeneic Transplantation and Advances in Treatment

点击蓝字关注我们 世界首例猪肾移植人体成功 10月19日,美国纽约大学朗格尼医学中心移植外科教授Montgom […]

← older
newer →
ABOUT US

The company was founded in 2004 with a registered capital of RMB 70.4 million and 185 employees worldwide, including 26 R&D staff members. The company focuses on organ transplantation as a provider of medical products and professional services for the global market around the entire transplant process. Focusing on the needs of organ transplantation surgeons and patients, we provides medical devices and professional services related to organ transplantation, mainly involving products for the preservation, transportation, evaluation and repair of transplanted organs and in vitro diagnostic reagents for individualized and precise diagnosis of transplant patients, which are exported to about 49 countries and regions worldwide.

FOLLOW US
CONTACT US
  • Tel: 021-61763507
  • Fax: 021-52370879
  • Address: Rm 1101, Bldg 2, Pujiang Hi-Tech Plaza, No. 2388 Chenhang Road, Minhang District, Shanghai
Rm 1101, Bldg 2, Pujiang Hi-Tech Plaza, No. 2388 Chenhang Road, Minhang District, Shanghai
Tel: 021-61763507 | Fax: 021-52370879
Shanghai Genext Medical Technology Co.Ltd
沪ICP备12033151号 Copyright © 2014 - 2023